| FARAMPATOR |
CX691 |
211735-76-1 |
| WBYNZQXAAWPAGR-UHFFFAOYSA-N |
CS-2866 |
1637300-25-4 |
| ISRIB (trans-isoMer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
| SGC0946 |
SGC0946 |
1561178-17-3 |
| ODM203 |
ODM203 |
1430723-35-5 |
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| 2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole |
2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole |
1401728-56-0 |
| pf-5274857 |
PF-5274857 |
1373615-35-0 |
| CID-49830258 |
ML240 |
1346527-98-7 |
| azd4635 |
AZD4635 |
1321514-06-0 |
| ACY-1215 |
ACY1215 |
1316214-52-4 |
| GDC-0032 |
GDC 0032 |
1282512-48-4 |
| mi503 |
MI-503 |
1857417-13-0 |
| 3-Amino-6-[4-(methylsulfonyl)phenyl]-N-phenyl-2-pyrazinecarboxamide |
3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 |
1232410-49-9 |
| VE 822 |
VE-822 |
1232416-25-9 |
| AZD9496 |
(E)-3-[3,5-二氟-4-[(1R,3R)-2-(2-氟-2-甲基丙基)-3-甲基-2,3,4,9-四氢-1H-吡啶并[3,4-B]吲哚-1-基]苯基]丙烯酸 |
1639042-08-2 |
| DLin-M-C3-DMA |
4-(N,N-二甲基氨基)丁酸(二亚油基)甲酯 |
1224606-06-7 |
| LOXO-101 |
拉罗替尼 |
1223403-58-4 |
| NVP-TNKS656 |
NVP-TNKS656 |
1419949-20-4 |
| Osimertinib mesylate |
AZD9291(甲磺酸盐) |
1421373-66-1 |
QQ
微信
